Apelin is a potent activator of tumour neoangiogenesis (Q40120855)

17 September 2017

Apelin is a potent activator of tumour neoangiogenesis (English)

1 reference

17 September 2017

Sorli SC

1

1 reference

17 September 2017

Le Gonidec S

series ordinal

2

1 reference

17 September 2017

Knibiehler B

series ordinal

3

1 reference

17 September 2017

Audigier Y

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

11 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

26

1 reference

17 September 2017

55

1 reference

17 September 2017

7692-7699

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210573

17 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Endothelial cells and VEGF in vascular development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin is a novel angiogenic factor in retinal endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin signalling: a promising pathway from cloning to pharmacology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Therapeutic potential of interfering with apelin signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210573

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210573

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference